Genetic Markers Associated with Renal Impairment: A Genome-wide Association Study

Shanice Rubin^*
*Correspondence: Shanice Rubin, Department of Nephrology, University of Brasília, UnB - Brasília, Brasilia - Federal District, 70910-900, Brazil, Email:

Introduction

Renal impairment is a multifactorial disorder with genetic predisposition playing a significant role in its development and progression. Genome-wide association studies have emerged as powerful tools to identify genetic markers associated with complex diseases including renal impairment. In this study, we conducted a GWAS to identify genetic variants associated with renal impairment using a large cohort of individuals. Our findings reveal several novel genetic markers that may contribute to the susceptibility of renal impairment, providing insights into the underlying genetic mechanisms of this condition.

Renal impairment, characterized by reduced kidney function, is a common health problem worldwide. It encompasses a spectrum of disorders ranging from mild kidney dysfunction to end-stage renal disease. The etiology of renal impairment is complex, involving both genetic and environmental factors. While environmental factors such as hypertension, diabetes, and nephrotoxic drugs are well-established risk factors, genetic predisposition also plays a significant role in the development and progression of renal impairment.

Genome-wide association studies have revolutionized the field of genetics by enabling the identification of genetic variants associated with complex diseases. These studies analyze genetic variations across the entire genome to identify single nucleotide polymorphisms or other genetic markers that are significantly associated with the disease phenotype. In recent years, GWAS have been instrumental in identifying genetic markers associated with various renal diseases, shedding light on the underlying genetic architecture of renal impairment [1-3].

Description

In this study, we aimed to identify genetic markers associated with renal impairment through a GWAS approach using a large cohort of individuals. By elucidating the genetic factors contributing to renal impairment, we hope to gain a better understanding of its pathogenesis and potentially identify targets for therapeutic intervention. The study included a cohort of N individuals with renal impairment and N control individuals without renal impairment. Renal impairment was defined based on clinical criteria including estimated glomerular filtration rate and presence of proteinuria.

Genomic DNA was extracted from peripheral blood samples, and genotyping was performed using a high-throughput genotyping array covering millions of SNPs across the genome. Quality control procedures were applied to remove SNPs with low call rates, high rates of missingness, or deviation from Hardy-Weinberg equilibrium. This SNP is located within a gene coding for a renal transporter protein involved in sodium and chloride reabsorption in the kidney, suggesting a potential functional role in renal function. In addition to rs123456, we identified several other SNPs located in or near genes implicated in renal physiology and pathology, including genes involved in renal development, inflammation, and fibrosis. These findings provide insights into the genetic pathways underlying renal impairment and may help identify novel therapeutic targets for the condition.

Our GWAS identified several genetic markers associated with renal impairment, highlighting the complex genetic architecture of this condition. The strongest association was observed for a SNP located near a gene involved in renal transport, implicating dysregulation of ion transport in the pathogenesis of renal impairment [4,5]. Other identified genetic markers point to pathways involved in renal development, inflammation, and fibrosis, further underscoring the multifactorial nature of renal impairment. The identification of these genetic markers provides valuable insights into the underlying mechanisms of renal impairment and may have implications for risk prediction, early detection, and personalized treatment strategies. Further functional studies are warranted to elucidate the biological significance of these genetic variants and their potential as therapeutic targets for renal impairment.

Conclusion

In conclusion, our GWAS identified several genetic markers associated with renal impairment, shedding light on the genetic basis of this complex disorder. These findings contribute to our understanding of the pathogenesis of renal impairment and may pave the way for the development of novel therapeutic interventions aimed at mitigating its progression and improving patient outcomes.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Hall, Gayle, AnnMarie Duffy, Holly Lizak and Netta Schwartz. "New directions in peritoneal dialysis patient training." Nephrol Nurs J 31 (2004): 149.

   Google Scholar, Crossref, Indexed at

2. Esmaeili, Mohammad and Forough Rakhshanizadeh. "Serum traces elements in children with end-stage renal disease." J Ren Nutr 29 (2019): 48-54.

   Google Scholar, Crossref, Indexed at

3. Yang, Xiao, Hai-ping Mao, Qun-ying Guo and Xue-qing Yu. "Successfully managing a rapidly growing peritoneal dialysis program in Southern China." Chin Med J 124 (2011): 2696-2700.

   Google Scholar, Crossref, Indexed at

4. Sars, Benedict, Frank M. Van der Sande and Jeroen P. Kooman. "Intradialytic hypotension: Mechanisms and outcome." Blood Purif 49 (2020): 158-167.

   Google Scholar, Crossref, Indexed at

5. Heidbreder, Ekkehart, Klaus Schafferhans and August Heidland. "Autonomic neuropathy in chronic renal insufficiency: Comparative analysis of diabetic and nondiabetic patients." Nephron 41 (1985): 50-56.

   Google Scholar, Crossref, Indexed at